Difference between revisions of "PET Amyloid Biomarker Ctte"
Jump to navigation
Jump to search
| (21 intermediate revisions by the same user not shown) | |||
| Line 20: | Line 20: | ||
==PET Amyloid Meetings/Call Summaries== | ==PET Amyloid Meetings/Call Summaries== | ||
| − | *[[Media: | + | *[[Media:2022_05-13_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 13, 2022]] |
| − | *[[Media: | + | *[[Media:2022_04-15_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|April 15, 2022]] |
| − | *[[Media: | + | *[[Media:2022_03-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 11, 2022]] |
| − | *[[Media: | + | *[[Media:2022_02-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 11, 2022]] |
| + | *[[Media:2022_01-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 14, 2022]] | ||
| + | |||
'''''[[PET Amyloid BC Call Summaries Archive]]''''' | '''''[[PET Amyloid BC Call Summaries Archive]]''''' | ||
==PET Amyloid Profile Development== | ==PET Amyloid Profile Development== | ||
| + | |||
| + | For NM CC vote - Technically Confirmed: | ||
| + | |||
| + | *[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-clean.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(clean version)-2022-04-14]] | ||
| + | *[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-redline.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(marked up version)-2022-04-14]] | ||
| + | *[[Media:QIBA_PET Amyloid_Profile_Updates_15April2022.pdf | Profile Updates Summary-2022-04-15]] | ||
| + | ---------------------------------------------------------- | ||
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]] | *[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]] | ||
Revision as of 15:42, 6 May 2022
- Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
There is a draft Profile, and current outline of the Claim is:
- SUVr will be the measurand
- The claim will have two components
- 1) Cross-sectional: single subject scan
- 2) Longitudinal: following subject over time
Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.
Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)
PET Amyloid Meetings/Call Summaries
PET Amyloid BC Call Summaries Archive
PET Amyloid Profile Development
For NM CC vote - Technically Confirmed:
- 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(clean version)-2022-04-14
- 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(marked up version)-2022-04-14
- Profile Updates Summary-2022-04-15
- QIBA PET Amyloid Profile 2017-06-15 (Closed on September 15, 2017)
- QIBA PET Amyloid Profile 2017-04-28 (BC Vote to Release for Public Comment Form: https://goo.gl/forms/0RqF8V6HlXlUNi903)
- QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman} February 10, 2017 (PDF)
- QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman} November 11, 2016 (PDF)
- QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman} July 7, 2016 (PDF)
- QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman} April 26 - May 5, 2016
Profile Supporting Material
Working Documents
Presentations and Reports
- 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 03 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 02 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews
- 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 08 12 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 2015-PET-Amyloid DRO Report – Drs. Pierce, Haynor, Sunderland, and Kinahan {Part I} - Discussed on 08 12 2016 WebEx
- 2015-PET-Amyloid DRO Report – Drs. Pierce, Haynor, Sunderland, and Kinahan {Part II} - Discussed on 08 12 2016 WebEx
- Conformance Formulae - Discussed on 08 12 2016 WebEx
- QIBA Conformance Draft - Discussed on 08 12 2016 WebEx